Showing 1 - 7 results of 7 for search 'Erika F Augustine', query time: 0.03s Refine Results
  1. 1
    The parent and family impact of CLN3 disease: an observational survey-based study

    The parent and family impact of CLN3 disease: an observational survey-based study by Angela Schulz, Nita Patel, Jon J. Brudvig, Frank Stehr, Jill M. Weimer, Erika F. Augustine

    Published 2024-03-01
    Get full text
    Article
  2. 2
    Un-Meetings as tools for translational idea generation: A semantic content analysis of an Opioid Crisis Un-Meeting

    Un-Meetings as tools for translational idea generation: A semantic content analysis of an Opioid Crisis Un-Meeting by Reza Yousefi Nooraie, Robert J. White, Scott Steele, Erika F. Augustine, Deborah J. Ossip, Martin S. Zand

    Published 2022-01-01
    Get full text
    Article
  3. 3
    Utilizing the Un-Meeting model to advance innovative translational and team science

    Utilizing the Un-Meeting model to advance innovative translational and team science by Erika F. Augustine, Scott J. Steele, Scott McIntosh, Laura Sugarwala, Robert J. White, Reza Yousefi-Nooraie, Martin S. Zand, Deborah J. Ossip

    Published 2023-01-01
    Get full text
    Article
  4. 4
    Assessing the integrity of auditory sensory memory processing in CLN3 disease (Juvenile Neuronal Ceroid Lipofuscinosis (Batten disease)): an auditory evoked potential study of the duration-evoked mismatch negativity (MMN)

    Assessing the integrity of auditory sensory memory processing in CLN3 disease (Juvenile Neuronal Ceroid Lipofuscinosis (Batten disease)): an auditory evoked potential study of the... by Tufikameni Brima, Edward G. Freedman, Kevin D. Prinsloo, Erika F. Augustine, Heather R. Adams, Kuan Hong Wang, Jonathan W. Mink, Luke H. Shaw, Emma P. Mantel, John J. Foxe

    Published 2024-01-01
    Get full text
    Article
  5. 5
    No sex differences in use of dopaminergic medication in early Parkinson disease in the US and Canada - baseline findings of a multicenter trial.

    No sex differences in use of dopaminergic medication in early Parkinson disease in the US and Canada - baseline findings of a multicenter trial. by Chizoba C Umeh, Adriana Pérez, Erika F Augustine, Rohit Dhall, Richard B Dewey, Zoltan Mari, David K Simon, Anne-Marie A Wills, Chadwick W Christine, Jay S Schneider, Oksana Suchowersky

    Published 2014-01-01
    Get full text
    Article
  6. 6
    Sex Differences in Clinical Features of Early, Treated Parkinson's Disease.

    Sex Differences in Clinical Features of Early, Treated Parkinson's Disease. by Erika F Augustine, Adriana Pérez, Rohit Dhall, Chizoba C Umeh, Aleksandar Videnovic, Franca Cambi, Anne-Marie A Wills, Jordan J Elm, Richard M Zweig, Lisa M Shulman, Martha A Nance, Jacquelyn Bainbridge, Oksana Suchowersky

    Published 2015-01-01
    Get full text
    Article
  7. 7
    A human model of Batten disease shows role of CLN3 in phagocytosis at the photoreceptor–RPE interface

    A human model of Batten disease shows role of CLN3 in phagocytosis at the photoreceptor–RPE interface by Cynthia Tang, Jimin Han, Sonal Dalvi, Kannan Manian, Lauren Winschel, Stefanie Volland, Celia A. Soto, Chad A. Galloway, Whitney Spencer, Michael Roll, Caroline Milliner, Vera L. Bonilha, Tyler B. Johnson, Lisa Latchney, Jill M. Weimer, Erika F. Augustine, Jonathan W. Mink, Vamsi K. Gullapalli, Mina Chung, David S. Williams, Ruchira Singh

    Published 2021-02-01
    Get full text
    Article

Search Tools: